• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年女性中抗吸收药物的使用:威斯康星州的一个案例研究。

Use of antiresorptive drugs among older women: a case study in Wisconsin.

作者信息

Cline Richard R, Mott David A

机构信息

Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, 308 Harvard Street, S.E., Minneapolis, MN 55455, USA.

出版信息

Am J Health Syst Pharm. 2003 Mar 1;60(5):453-63. doi: 10.1093/ajhp/60.5.453.

DOI:10.1093/ajhp/60.5.453
PMID:12635451
Abstract

The factors contributing to the use of antiresorptive therapies (ARTs) and differentiating the ARTs used were examined. A list of names of community-dwelling persons 65 years or older living in Wisconsin was obtained, and 2100 individuals were selected (1050 men and 1050 women) to receive the 10-page survey instrument. The survey requested information on health status, prescription drug use, preferences for using prescription drugs versus self-treatment strategies, demographic characteristics, and status and type of prescription drug and medical insurance. Only the responses from female respondents were evaluated. Descriptive statistics were calculated for each variable. The simultaneous relationships among all variables were modeled sequentially using a binary logistic regression model and a multinomial logistic regression model. Usable responses were received from 629 women, yielding an adjusted response rate of 59.9%; 169 (26.9%) reported current use of at least one ART, 110 (17.5%) reported using hormone replacement therapy (HRT), and 59 (9.4%) were using newer ARTs. The typical respondent did not use any prescription medicines for the treatment or prevention of osteoporosis, was married, and did not have a four-year college degree. Married, younger women with high medical care preferences scores were more likely to use antiresorptive agents. Married women were more likely to use HRT versus no treatment. A higher number of family practice physicians per 100,000 population reduced the likelihood of the use of any ART. Lower age was also related to the use of ARTs. Marital status, age, medical care preferences, prescription drug insurance, a regular source of care, and the diagnosis of osteoporosis were all significantly associated with the use of any antiresorptive agent.

摘要

研究了促成抗吸收疗法(ARTs)使用以及区分所使用的ARTs的因素。获取了威斯康星州65岁及以上社区居住者的名单,并挑选了2100人(1050名男性和1050名女性)来接收这份10页的调查问卷。该调查询问了健康状况、处方药使用情况、使用处方药与自我治疗策略的偏好、人口统计学特征以及处方药和医疗保险的状况及类型。仅对女性受访者的回答进行了评估。对每个变量进行了描述性统计。使用二元逻辑回归模型和多项逻辑回归模型依次对所有变量之间的同步关系进行建模。收到了629名女性的可用回复,调整后的回复率为59.9%;169人(26.9%)报告目前至少使用一种ART,110人(17.5%)报告使用激素替代疗法(HRT),59人(9.4%)使用新型ART。典型的受访者未使用任何用于治疗或预防骨质疏松症的处方药,已婚,且没有四年制大学学位。医疗保健偏好得分高的已婚年轻女性更有可能使用抗吸收剂。已婚女性比不接受治疗的女性更有可能使用HRT。每10万人口中家庭医生数量较多会降低使用任何ART的可能性。年龄较小也与ART的使用有关。婚姻状况、年龄、医疗保健偏好、处方药保险、固定的医疗来源以及骨质疏松症的诊断均与任何抗吸收剂的使用显著相关。

相似文献

1
Use of antiresorptive drugs among older women: a case study in Wisconsin.老年女性中抗吸收药物的使用:威斯康星州的一个案例研究。
Am J Health Syst Pharm. 2003 Mar 1;60(5):453-63. doi: 10.1093/ajhp/60.5.453.
2
Osteoporosis beliefs and antiresorptive medication use.骨质疏松症认知与抗吸收药物的使用
Maturitas. 2005 Mar 14;50(3):196-208. doi: 10.1016/j.maturitas.2004.05.004.
3
Resorptive drug use among community-dwelling women in Minnesota.明尼苏达州社区居住女性中吸收性药物的使用情况。
Am J Health Syst Pharm. 2004 Aug 1;61(15):1577-85. doi: 10.1093/ajhp/61.15.1577.
4
Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers.疗养院居民和社区居民抗吸收药物治疗的不同模式。
J Am Geriatr Soc. 2005 Aug;53(8):1275-81. doi: 10.1111/j.1532-5415.2005.53401.x.
5
Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.老年女性骨质疏松症抗吸收药物使用的趋势及决定因素
Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95. doi: 10.1002/pds.1068.
6
Comparing therapies for postmenopausal osteoporosis prevention and treatment.比较绝经后骨质疏松症的预防和治疗方法。
Ann Pharmacother. 2003 May;37(5):711-24. doi: 10.1345/aph.1C246.
7
Comparative risks for cancer associated with use of calcitonin, bisphosphonates or selective estrogen receptor modulators among osteoporosis patients: a population-based cohort study.骨质疏松症患者使用降钙素、双膦酸盐或选择性雌激素受体调节剂与癌症相关的比较风险:一项基于人群的队列研究。
Jpn J Clin Oncol. 2017 Oct 1;47(10):935-941. doi: 10.1093/jjco/hyx111.
8
Pharmacotherapeutics for osteoporosis prevention and treatment.
J Midwifery Womens Health. 2003 Jan-Feb;48(1):39-52. doi: 10.1016/s1526-9523(02)00359-8.
9
Mortality and morbidity associated with osteoporosis drug treatment following hip fracture.髋部骨折后骨质疏松症药物治疗相关的死亡率和发病率
Osteoporos Int. 2003 Sep;14(9):722-7. doi: 10.1007/s00198-003-1430-3. Epub 2003 Aug 7.
10
[Treatment of postmenopausal osteoporosis].[绝经后骨质疏松症的治疗]
An Sist Sanit Navar. 2003;26 Suppl 3:91-8.

引用本文的文献

1
Methods to Assess Patient Preferences in Old Age Pharmacotherapy - A Systematic Review.评估老年药物治疗中患者偏好的方法——一项系统评价
Patient Prefer Adherence. 2020 Mar 4;14:467-497. doi: 10.2147/PPA.S236964. eCollection 2020.